Lineage Cell Therapeutics (LCTX) Insider Trading & Ownership $1.30 -0.02 (-1.52%) Closing price 05/22/2026 04:10 PM EasternExtended Trading$1.30 -0.01 (-0.38%) As of 05/22/2026 06:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestBuy This Stock Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage24.70%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$24.30KNumber OfInsiders Selling(Last 12 Months)0 Get LCTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Lineage Cell Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. LCTX Insider Buying and Selling by Quarter Lineage Cell Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/12/2026Brian M CulleyCEOBuy15,000$1.62$24,300.00 (Data available from 1/1/2013 forward) LCTX Insider Trading Activity - Frequently Asked Questions Who is on Lineage Cell Therapeutics' Insider Roster? The list of insiders at Lineage Cell Therapeutics includes Brian M Culley, Broadwood Partners, L.P., Don M Bailey, and Jill Ann Howe. Learn more on insiders at LCTX. What percentage of Lineage Cell Therapeutics stock is owned by insiders? 24.70% of Lineage Cell Therapeutics stock is owned by insiders. Learn more on LCTX's insider holdings. Which Lineage Cell Therapeutics insiders have been buying company stock? The following insiders have purchased LCTX shares in the last 24 months: Brian M Culley ($58,800.00), and Jill Ann Howe ($9,345.00). How much insider buying is happening at Lineage Cell Therapeutics? Insiders have purchased a total of 75,500 LCTX shares in the last 24 months for a total of $68,145.00 bought. More Insider Trading Tools from MarketBeat Related Companies OLMA Insider Transactions MPLT Insider Transactions MAZE Insider Transactions CMPS Insider Transactions MRVI Insider Transactions COLL Insider Transactions DBVT Insider Transactions XERS Insider Transactions SEPN Insider Transactions SVRA Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Latest Articles 3 Dividend Stocks With Insiders Buying in 2026Insider Buying Says Upstart Isn’t Down for the CountInsider Trades: Okta and Abbott See Buys, Micron Insiders SellMarketBeat Week in Review – 05/04 - 05/08BlackBerry Rewrites Its Own Operating System This page (NYSEAMERICAN:LCTX) was last updated on 5/24/2026 by MarketBeat.com Staff. From Our PartnersHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredPH: Do THESE 4 things to your bank account now …In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...Weiss Ratings | SponsoredYour computer is about to become a museum pieceFuturist George Gilder - who predicted the smartphone years before the iPhone launched - believes today's AI d...Eagle Publishing | SponsoredGold surged 600 dollars last time this indicator peakedThe Buffett Indicator has predicted every major gold bull run this century - 2000, 2008, and 2020, when gold s...Porter & Company | SponsoredJune 12: Elon Musk’s “Day-One Retirement Plan.”SpaceX is expected to go public on June 12 - and for the first time, everyday investors may have a way in befo...Brownstone Research | SponsoredJune 4: The day smart money moves (not June 12)Everyone is watching June 12 - the SpaceX listing date. The real deadline is June 4, when Goldman Sachs, Morga...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lineage Cell Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lineage Cell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
